Table 4.
ALI etiology | Progression to ALF |
Time from enrollment to death (days) |
Cause of death |
---|---|---|---|
1. APAP | No | 2 | Cardiac arrest |
2. Hepatitis B | Yes | 3 | Multisystem organ Failure/sepsis |
3. Shock/ischemia | Yes | 11 | Unknown |
4. Autoimmune hepatitis | Yes | 16 | Unknown |
5. DILI | Yes | 8 | Multisystem organ failure |
6. APAP | Yes | 8 | Neurological (cerebral edema) |
7. Indeterminate | No | 1 | Unknown |
8. Indeterminate | Yes | 11 | Neurological (cerebral edema) |
9. APAP | No | 8 | Pulmonary embolism |
10. Autoimmune hepatitis | Yes | 7 | Liver failure |
11. Indeterminate | Yes | 4 | Multisystem organ failure/sepsis |
12. Autoimmune hepatitis | No | 13 | Multisystem organ Failure |
13. Autoimmune hepatitis | Yes | 4 | PEA arrest |
14. Shock/ischemia | No | 14 | Multisystem organ failure |
15. APAP | No | 10 | Liver failure |
16. Hepatitis B | No | 9 | Liver failure |
17. Indeterminate | No | 18 | Unknown |
18. Hepatitis B | No | 20 | Liver failure |
19. Autoimmune hepatitisa | Yes | 17 | Intracardiac thrombosis |
ALI, acute liver injury; ALF, acute liver failure; APAP, N-acetyl-p-aminophenol; DILI, drug-induced liver injury; PEA, pulseless electrical activity.
Patient died shortly after liver transplant.